Lantern Pharma Inc. (LTRN): A Penny Stock with Incredible Growth Potential

According to Yahoo Finance, Lantern Pharma: LTRN Overall ranks 10th on their list of "Penny Stocks that will Make You a Millionaire". Lantern Pharma Inc. (NASDAQ: LTRN) is a promising penny stock in the biotech sector, driven by its focus on AI in drug development. The company has three drugs in clinical trials—LP-184, LP-284, and LP-300—and has formed strategic partnerships with Oregon Therapeutics and Starlight Therapeutics. 

In 2023, Lantern's AI platform, RADR®, expanded to over 60 billion data points. Their new goal of reaching 100 billion in 2024 will enhance its drug efficacy predictions and clinical trial optimization. These advancements position Lantern Pharma as a potentially lucrative investment within the biotech industry, especially for those interested in the intersection of AI and healthcare.

Learn more